July, 2008: Finasteride Registered in KSA Market TPMC has successfully registered a branded generic “Finasteride” in the segment of Benign Prostate Hypertension where the market value of this therapeutic segment is $14.66 million. Tabuk plans to launch this product later this year.
Return